Vous êtes ici

Telecure Technologies Inc.

Telecure Technologies Inc.
Liste d'échange: 
CSE
Statut: 
Suspended
Industrie: 
Technology
Symbole: 
TELE
Indice CSE: 
Devise: 

Telecure Technologies Inc. (“Telecure”) is a health information technology company that provides complete telemedicine and telehealth services for the betterment of patients and offers doctors tools to better manage their clients. Telecure is focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry for the purpose of improving the efficiency of services provided by healthcare professionals by unlocking the value of technology. Telecure’s overarching goal is to digitalize the provision of healthcare services to patients such that patients have access to all points of their care from their smartphone, tablet or computer, thereby increasing accessibility, convenience and affordability of healthcare for patients. Parallel to its overarching goal, Telecure aims to increase productivity, efficiency, revenue for healthcare providers by enabling healthcare providers to efficiently capture billable time, reduce the cost associated with no-shows and increase access to patient base and practice reach.

Vous êtes ici

Telecure Technologies Inc. (TELE)

SEDAR Information

Information d'entreprise

Addresse
1930 - 1177 West Hastings Street
Vancouver, BC V6E 3T4
Canada
Téléphone
604-398-3432
Courriel
invest@telecuretech.com
URL
http://telecuretech.com/
Date d’inscription à la cote
Mardi, août 31, 2021
Agent de transfert
Odyssey Trust Company
Courriel
invest@telecuretech.com

Capitalisation

Capitalisation: 
84320299
Réservé à l'émission: 
16615992

Bulletins

11/07/2022

2022-0708 – Suspensions (MCCN, MEAL, WBIO, TELE, GBMC, CBDN)

Le 11 juillet/July 2022

Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules.  Cease Trade Orders have been issued by one or more securities commissions.